Corcept Therapeutics (CORT)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

55.40

0.00%

After-hours Dec 13, 2024, 05:19 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03	FY02	FY01
Revenue	482.38M	401.86M	365.98M	353.87M	306.49M	251.25M	159.20M	81.32M	50.29M	26.55M	10.36M	3.31M	-	-	29.00K	209.00K	482.00K	294.00K	-	-	-	-	-
Cost of Revenue	6.48M	5.38M	5.28M	5.58M	5.50M	5.21M	3.55M	2.06M	1.36M	882.00K	143.00K	91.00K	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	475.89M	396.47M	360.70M	348.29M	300.98M	246.03M	155.65M	79.26M	48.92M	25.67M	10.21M	3.22M	-	-	29.00K	209.00K	482.00K	294.00K	-	-	-	-	-
Operating Income	107.28M	112.63M	124.48M	128.20M	111.61M	89.50M	52.85M	10.18M	-3.44M	-27.62M	-41.50M	-36.27M	-32.33M	-27.44M	-20.25M	-19.69M	-12.24M	-25.58M	-21.16M	-16.04M	-9.99M	-18.80M	-8.01M
Interest Income	17.27M	3.56M	529.00K	3.40M	5.07M	2.66M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pretax Income	124.56M	116.19M	125.01M	131.60M	116.68M	92.15M	52.81M	8.14M	-6.41M	-31.38M	-46.01M	-38.05M	-32.35M	-25.97M	-20.17M	-20.06M	-11.57M	-24.87M	-20.09M	-15.53B	-	-	-
Net Income	106.14M	101.42M	112.51M	106.01M	94.18M	75.41M	129.12M	8.14M	-6.41M	-31.38M	-46.01M	-38.05M	-32.35M	-25.97M	-20.17M	-20.06M	-11.57M	-24.87M	-20.09M	-15.53M	-9.81M	-18.50M	-7.45M
Selling & General & Admin	184.26M	152.85M	122.36M	105.33M	100.36M	81.29M	62.42M	45.24M	36.95M	34.92M	31.24M	25.41M	11.33M	8.49M	5.88M	5.75M	4.87M	5.04M	4.08M	4.49M	1.89M	5.53M	2.62M
Research & Development	184.35M	130.99M	113.86M	114.76M	89.02M	75.25M	40.38M	23.84M	15.42M	18.37M	20.47M	14.07M	21.00M	18.95M	14.40M	14.15M	7.86M	20.83M	17.07M	11.55M	8.11M	13.26M	5.39M
Other Expenses	-	-	-	-	-	-	-	-	-	-	-	-	8.44M	6.59M	4.33M	4.39M	4.02M	4.03M	3.29M	3.02B	-	-	-
Operating Expenses	368.61M	283.84M	236.22M	220.09M	189.38M	156.54M	102.79M	69.08M	52.37M	53.29M	51.71M	39.49M	32.33M	27.44M	20.28M	19.90M	12.73M	25.88M	21.16M	16.04M	9.99M	18.80M	8.01M
Interest Expense	-	3.56M	-	-	5.07M	2.66M	49.00K	2.04M	2.96M	3.76M	4.51M	1.78M	3.00K	1.50M	101.00K	944.00K	-	-	-	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4.49B	-	-	-
Cost & Expenses	375.09M	289.22M	241.50M	225.67M	194.88M	161.75M	106.35M	71.14M	53.73M	54.17M	51.85M	39.58M	32.33M	27.44M	20.28M	19.90M	12.73M	25.88M	21.16M	16.04M	9.99M	18.80M	8.01M
Income Tax	18.42M	14.77M	12.49M	25.59M	22.50M	16.74M	-76.32M	-	-	-	-	-	22.00K	-1.47M	-84.00K	372.00K	-672.00K	-709.00K	-1.06M	-510.35K	-182.23K	18.50M	7.45M
Shares Outstanding (Basic)	103.56M	106.79M	115.65M	115.41M	114.35M	125.68M	113.53M	110.57M	106.80M	100.98M	99.82M	93.02M	83.31M	68.34M	52.44M	46.72M	34.25M	22.84M	22.61M	18.44M	8.65M	6.72M	5.38M
Shares Outstanding (Diluted)	111.74M	115.97M	125.96M	124.19M	122.57M	126.69M	124.52M	116.14M	106.88M	100.98M	99.82M	93.02M	83.31M	68.34M	52.44M	46.72M	34.25M	22.84M	22.61M	18.44M	8.65M	6.72M	5.38M
EPS (Basic)	1.02	0.95	0.97	0.92	0.82	0.60	1.14	0.07	-0.06	-0.31	-0.46	-0.41	-0.39	-0.38	-0.38	-0.43	-0.34	-1.09	-0.89	-0.84	-1.13	-2.75	-1.39
EPS (Diluted)	0.94	0.87	0.89	0.85	0.77	0.60	1.04	0.07	-0.06	-0.31	-0.46	-0.41	-0.39	-0.38	-0.38	-0.43	-0.34	-1.09	-0.89	-0.84	-1.13	-2.75	-1.39
EBITDA	108.32M	112.63M	124.48M	130.44M	113.78M	89.73M	52.96M	10.27M	-3.29M	-27.48M	-41.42M	-36.24M	-32.35M	-25.96M	-20.25M	-19.69M	-12.24M	-25.58M	-20.09M	-15.47M	-9.97M	-18.80M	-8.01M
Depreciation & Amortization	1.04M	2.97M	3.07M	2.24M	2.17M	236.00K	106.00K	87.00K	155.00K	141.00K	74.00K	27.00K	3.00K	6.00K	10.00K	12.00K	13.00K	14.00K	704.00K	1.61M	22.55K	-	-